Print version ISSN 0365-0596
An. Bras. Dermatol. vol.85 no.3 Rio de Janeiro June 2010
Melanocyte transplant in piebaldism - case report*
Daniela Rezende NevesI; José Rogério Régis JúniorII; Patrícia Jannuzzi Vieira e OliveiraIII; Renata Indelicato ZacIV; Kleber de Sousa SilveiraV
ISpecializing physician attending
the specialization course implemented in partnership with the Faculty of Medical
Sciences of Minas Gerais/ Research and Postgraduate Center, Service of Dermatology,
Santa Casa Hospital of Belo Horizonte - Belo Horizonte (MG), Brazil
IIPreceptor of Surgical Dermatology, Santa Casa Hospital of Belo Horizonte - Belo Horizonte (MG), Brazil
IIISpecializing physician attending the specialization course implemented in partnership with the Faculty of Medical Sciences of Minas Gerais/ Research and Postgraduate Center, Service of Dermatology, Santa Casa Hospital of Belo Horizonte - Belo Horizonte (MG), Brazil
IVResident in Dermatology, Service of Dermatology, Santa Casa Hospital of Belo Horizonte, attending the specialization course implemented in partnership with the Faculty of Medical Sciences of Minas Gerais / Research and Postgraduate Center - Belo Horizonte (MG), Brazil
VSpecializing physician attending the specialization course implemented in partnership with the Faculty of Medical Sciences of Minas Gerais/ Research and Postgraduate Center, Service of Dermatology, Santa Casa Hospital of Belo Horizonte - Belo Horizonte (MG), Brazil
Piebaldism is a rare genodermatosis in which depigmented skin areas are unresponsive to topical or light treatment. This article describes the importance of transplant techniques using noncultured melanocytes (minigrafting) in the treatment of piebaldism.
Keywords: Melanocytes; Piebaldism; Transplantation
Piebaldism, or partial albinism, is a rare, autosomal dominant genodermatosis with no preference for color or race.1
The classical clinical symptoms present at birth are a white forelock of scalp hair (poliosis) in about 90% of the cases and symmetrical depigmented maculae in the skin.1 Depigmented hair presents as an often triangular-shaped leucodermic macula, whose base penetrates the hair scalp up to the bregma (the junction of the sagittal and coronal sutures at the top of the skull) and whose vertex extends until the eyelash line and nasal bridge causing, oftentimes, whitening of hair in the medial portion of the eyebrows. Leucotrichia can involve pubic and axillary hair.
Skin depigmentation is also very distinct. Always present at birth, white patches are characterized by rigorous symmetry and affect mostly the face, anterior portion of the thorax and abdomen, arms, forearms, legs, and thighs. They remain stationary or show limited and discreet evolution, with proportional enlargement of the area as the patient grows.
Another significant detail is the presence of small hyperpigmented maculae in leucodermic lesions, an important differential diagnosis of piebaldism and vitiligo, and also in normal skin.
Piebaldism appears to be associated with a reduced expression of the KIT receptor, a consequence of various mutations in the C-KIT gene in chromosome 4. This results in an abnormal distribution and lower proliferation of melanoblasts in embryonic life.2-4 Therefore, there is absence of melanin in the epidermis due to lack of melanocytes.5 Achromic areas show partial loss of the barrier to ultraviolet radiation and are unresponsive to topical and light treatment.6-9
Male patient, 31 years old, leucoderma, has presented since his birth a triangular-shaped achromic macula with poliosis in the frontal region (Figure 1), and an achromic lesion in the right pretibial region. His father and grandfather on his father's side suffered from a similar clinical condition. The patient did not have other lesions. He was bothered by the lesion on his right lower extremity and did not want to treat the frontal lesion.
Three sessions of melanocyte transplantation were performed, with a four-month interval between them and approximately 60 skin grafts in each session, using the punch or minigrafting technique. 1.25 mm punches were done in the suprapubic region (donor area) and 1 mm punches, at a distance of 5 mm, were done in the right pretibial region (receptor area) (Figure 2). No other previous or associated treatment was conducted. Nearly two months after the first session, we observed a repigmentation halo with a diameter 5 times larger than the original one (Figures 3A and 3B). Pigmentation increased progressively with more than 90% improvement of the right pretibial lesion (Figures 4 and 5). Unaesthetic scars were neither observed in the donor area, where microscars were covered by pubic hair, nor in the receptor area.
Several methods of autologous melanocyte transplantation have been developed to treat leucodermic lesions that are unresponsive to clinical therapy. 7 Stable forms of leucodermia, such as segmental vitiligo and piebaldism, often respond to treatment with 100% repigmentation, regardless of the technique used.8 For these types of leucodermia, surgery seems to be the method of choice, but patients selected cannot be prone to forming hypertrophic scars or keloids.9 Techniques include transfer of melanocytes by total or partial skin graft, punch (minigrafting) or suction bubbles. Autologous melanocytes can also be obtained through the culture of melanocytes or of melanocytes and keratinocytes. 4 In a study, the minigrafting technique showed the highest levels of adverse effects; however, it was the easiest and most inexpensive procedure, since it does not require special equipment or laboratory, and it takes approximately 45 minutes for 50 cm2.5 In receptor areas, a cobblestone appearance is a considerable adverse effect of the minigrafting technique when punches larger than 1.25 mm are used. This can be avoided with a more superficial punch in the donor area and a deeper punch in the receptor site. This appearance may also improve spontaneously. 10 Nevertheless, scarring in the donor area is still the greatest limitation of this technique. Based on our experience, we have seen excellent cosmetic results when pilous areas (for instance, the pubic region) are chosen as donor sites and when punches of at most 1.25 mm are used. Falabella et al. showed that minigrafting can be an effective supplementary procedure to restore complete repigmentation (approximately 100%) when areas of achromia still remain after skin graft has been performed through other techniques.5
The micropunch (1 to 1.25 mm) transplantation technique is an easy and inexpensive method which, based on our observations, has excellent aesthetic results and practically no complications. This case report shows the importance of melanocyte transplantation to treat lesions of piebaldism. Dermopigmentation was the only treatment option before the introduction of this technique. It is widely known that melanocyte transplantation is the treatment of choice for lesions of piebaldism because it is a safe and effective technique.11
1. Gontijo B, Silva CMR, Pereira LB, Rocha AS. Piebaldismo - Relato de 2 casos. An Bras Dermatol.1996;71:503-5. [ Links ]
2. Spritz RA. Molecular basis of human piebaldism. J Invest Dermatol.1994;103:1375-1405. [ Links ]
3. Spritz RA, Holmes SA, Itim P, Kuster W. Novel mutations of the KIT (mast'stem cell growth factor receptor) proto-oncogen in human piebaldism. J Invest Dermatol.1983; 101:22-25. [ Links ]
4. Spritz RA, Droetto S, Fukushima Y. Deletion of the KIT and PDGFRA genes in a patient with piebaldism. Am J Med Genet.1992;44:492-5. [ Links ]
5. Tomita Y. The molecular genetics of albinism and piebaldism. Arch Dermatol.1994; 130:355-8. [ Links ]
6. McGovern TW, Bolognia J, Leffell DJ. Flip - Top Pigment Transplantation: A Novel Transplantation Procedure for the Treatment of Depigmentation. Arch Dermatol. 1999; 135:1305-7. [ Links ]
7. Njoo MD, Nieuweboer-krobotova L, Westerhof W. Repigmentation of leucodermic defects in piebaldism by dermabrasion and thin split-thickness skin grafting in combination with minigrafting. Br J Dermatol.1998;139:829-33. [ Links ]
8. Olsson MJ, Juhlin L. Long-term follow-up of leucoderma patients treated with transplants of autologous cultered melanocytes, ultrathin epidermal sheets and basal cell layer suspension. Br J Dermatol. 2002;147:893-904. [ Links ]
9. Njoo MD, Westerhof W, Bos JD, Bossuyt PMM. A systematic review of autologous transplatation methods in vitiligo. Arch Dermatol.1998;134:1543-9. [ Links ]
10. Barman K, Khaitan B. A Comparative Study of Punch grafting followed by topical corticosteroid versus Punch grafting followed by PUVA therapy in stable vitiligo. Dermatol Surg. 2004;30:49-53. [ Links ]
11. Selmanowitz VJ. Pigmentary correction of piebaldism by autografts II. Pathomechanism and pigment spread in piebaldism. Cutis.1979;24:66-73. [ Links ]
Mailing Address: Received on 08.12.2008. * Work conducted
at the Research and Postgraduate Center of the Faculty of Medical Sciences of
Minas Gerais (CPG-FCMMG) - Santa Casa Hospital of Belo Horizonte - Belo Horizonte
Daniela Rezende Neves
Rua Rio Grande do Sul 1030 / apt.2002 Bairro
30170 111 Belo Horizonte MG
Tel.: 31 9427 77-44
Approved by the Advisory Board and accepted for publication on 21.09.09.
Conflict of interest: None
Financial funding: None
Received on 08.12.2008.
* Work conducted at the Research and Postgraduate Center of the Faculty of Medical Sciences of Minas Gerais (CPG-FCMMG) - Santa Casa Hospital of Belo Horizonte - Belo Horizonte (MG), Brazil.